Showing 7991-8000 of 8647 results for "".
- My Eyelab and Stanton Optical to Offer Only Telehealth in Response to COVID-19 Crisishttps://modernod.com/news/my-eyelab-and-stanton-optical-to-offer-only-telehealth-in-response-to-covid-19-crisis/2477438/My Eyelab and Stanton Optical, retail brands of Now Optics, announced that in response to the COVID-19 crisis, they will immediately be offering only telehealth eyecare at 119 participating locations across the nation, according to a
- Coronavirus Vaccine Trials Could Start in UK Within a Monthhttps://modernod.com/news/coronavirus-vaccine-trials-could-start-in-uk-within-a-month/2477440/Trials of a coronavirus vaccine could begin within the next month, the UK’s health agency has said, as it prepares to start evaluating a drug developed by Oxford University, according to a report in The Telegraph. Scientists at Public Health England (PHE) could give the go-ahead for
- Doctors Turn to Malaria Drugs as Potential Coronavirus Treatmenthttps://modernod.com/news/doctors-turn-to-malaria-drugs-as-potential-coronavirus-treatment/2477434/Doctors and hospitals are turning to chloroquine phosphate and hydroxychloroquine to treat patients infected with COVID-19, as the antimalarial drugs have both shown early signs of improving symptoms of some patients diagnosed with COVID-19, based on reports by doctors and researchers in South Ko
- Novartis, Mylan and Teva to Supply Tens of Millions of Chloroquine Tablets to Fight COVID-19https://modernod.com/news/novartis-mylan-and-teva-to-supply-tens-of-millions-of-chloroquine-tablets-to-fight-covid-19/2477430/As efforts to discover new COVID-19 medicines roll on, President Donald Trump and others this week focused attention on the decades-old malaria drug chloroquine. Bayer got things rolling with an initial donation of the drug, and now Novartis, Mylan and Teva are takin
- President of Glaucoma Research Foundation Issues Messagehttps://modernod.com/news/president-of-glaucoma-research-foundation-issues-message/2477429/The Glaucoma Research Foundation sent an email to its membership on Friday, answering questions that glaucoma specialists may have during the COVID-19 pandemic. The letter reads: Dear Friends, Your health and well-being are on our minds as we all deal with a national and glob
- A Majority of ECPs Reduce Office Hours, Expect Lower Revenues as COVID-19 Situation Expands, Survey Findshttps://modernod.com/news/a-majority-of-ecps-reduce-office-hours-expect-lower-revenues-as-covid-19-situation-expands-jobson-research-survey-finds/2477428/Almost four in five eyecare professionals (primarily independent optometrists and opticians) have taken steps, or are considering, a move to reduce office hours, and about four in 10 are considering temporarily closing their offices in response to the coronavirus outbreak, according to a
- My Eyelab and Stanton Optical Shifts to Solely Telehealth Eyecare to Serve Communityhttps://modernod.com/news/my-eyelab-and-stanton-optical-shifts-to-solely-telehealth-eyecare-to-serve-community/2477426/My Eyelab and Stanton Optical, retail brands of Now Optics will immediately be switching to virtual eye care at 119 participating locations across the nation. In partnership with the Physicians Eyecare Group, select locations will offer patients the opportunity to receive eye care through telemed
- Keeping Your Vision Safe During a Natural Disasterhttps://modernod.com/news/keeping-your-vision-safe-during-a-natural-disaster/2477424/Parkhurst Nuvision in San Antonio, Texas, posted the following advisory to its patients, which providing tips for managing vision needs in an emergency. When faced with the forces of nature – in particular flooding and contaminated waters – people who rely on contact lenses to see well fa
- HIV Drug Failed to Help Patients With Severe Cases of COVID-19https://modernod.com/news/hiv-drug-failed-to-help-patients-with-severe-cases-of-covid-19/2477425/A potential coronavirus treatment has failed in a randomized clinical trial in China. A group of Chinese researchers tested the HIV drug Kaletra in a group of patients with severe cases of COVID-19, the disease caused by the novel coronavirus, according to a
- Facing the COVID-19 Threat, More Optical Retailers and ECPs Make the Tough Decision to Temporarily Close Locations or Modify Serviceshttps://modernod.com/news/facing-the-covid-19-threat-more-optical-retailers-and-ecps-make-the-tough-decision-to-temporarily-close-locations-or-modify-services/2477420/As the impact and spread of the coronavirus pervades much of the U.S., several more major regional and national optical retailers and eyecare practices have made the difficult decision to close their doors temporarily or modify their hours and services to customers and patients, according to a Vi